Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(10):743; doi:10.1093/jnci/93.10.743
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Theisen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theisen, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 10, 743, May 16, 2001
© 2001 Oxford University Press

NEWS

Chemoprevention: What’s in a Name?

Christine Theisen

As focus and funding for cancer research broadens to find more ways to prevent the beginning of the carcinogenic process, the concept of chemoprevention becomes increasingly important.

Chemoprevention is the use of pharmacologic or natural agents that inhibit the development of invasive cancer either by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Dwivedi, X. Guan, W. L. Harmsen, A. L. Voss, D. E. Goetz-Parten, E. M. Koopman, K. M. Johnson, H. B. Valluri, and D. P. Matthees
Chemopreventive Effects of {alpha}-Santalol on Skin Tumor Development in CD-1 and SENCAR Mice
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 151 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Gerhauser, A. Alt, E. Heiss, A. Gamal-Eldeen, K. Klimo, J. Knauft, I. Neumann, H.-R. Scherf, N. Frank, H. Bartsch, et al.
Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop
Mol. Cancer Ther., September 1, 2002; 1(11): 959 - 969.
[Abstract] [Full Text] [PDF]